SCHEMBL367373

SCHEMBL367373

CC1CCC(C(C)C)C(C(=O)Nc2ccc(CO)cc2)C1

nearest known ligand 0.70

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 4/20 0.70
EPHX1 P07099 1/20 0.47
SERPINE1 P05121 1/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
LMNA P02545 1/20 0.40
TRPV1 Q8NER1 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CYP19A1 P11511 2/20 0.40
ALDH1A1 P00352 1/20 0.40
P2RX4 Q99571 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15133477 1.00 TRPM8 (0.70) TRPM8EPHX1SERPINE1MEN1KMT2A
SCHEMBL2628643 1.00 TRPM8 (0.70) TRPM8EPHX1SERPINE1MEN1KMT2A
SCHEMBL2628636 0.90 TRPM8 (0.67) TRPM8EPHX1SERPINE1MEN1KMT2A
SCHEMBL2628763 0.90 TRPM8 (0.70) TRPM8EPHX1SERPINE1MEN1KMT2A
SCHEMBL14022692 0.89 TRPM8 (0.69) TRPM8EPHX1SERPINE1MEN1KMT2A
SCHEMBL12715179 0.88 TRPM8 (0.67) TRPM8EPHX1SERPINE1MEN1KMT2A
SCHEMBL10073862 0.88 TRPM8 (0.67) TRPM8EPHX1SERPINE1NPC1RAB9A
SCHEMBL661766 0.88 TRPM8 (0.67) TRPM8EPHX1SERPINE1NPC1RAB9A
SCHEMBL4889653 0.88 TRPM8 (0.67) TRPM8EPHX1SERPINE1MEN1KMT2A
SCHEMBL23187800 0.87 TRPM8 (0.66) TRPM8EPHX1SERPINE1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 271 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112423729-B Oral care compositions with improved efficacy of deposition of cooling sensates in the oral cavity 宝洁公司 2023-07-11 CN claimed
CN-113133950-A Composition and solution for refreshing and relieving fatigue and application thereof 深圳全棉时代科技有限公司 2021-07-20 CN claimed
CN-112423729-A Oral care compositions with improved deposition of cooling sensates in the oral cavity 宝洁公司 2021-02-26 CN claimed
US-10871363-B2 Oral care composition with improved deposition efficacy of a cooling sensate agent in the oral cavity THE PROCTER & GAMBLE COMPANY (US) 2020-12-22 US claimed
EP-3134081-B1 CYCLOHEXANECARBOXAMIDE WITH COOLING PROPERTIES PROCTER & GAMBLE (US) 2020-04-22 EP claimed
US-20190276389-A1 SYNTHESIS OF ARYL CYCLOHEXANE ESTER DERIVATIVES USEFUL AS SENSATES IN CONSUMER PRODUCTS THE PROCTER & GAMBLE COMPANY 2019-09-12 US claimed
EP-3390352-A1 SYNTHESIS OF CYCLOHEXANE ESTER DERIVATIVES USEFUL AS SENSATES IN CONSUMER PRODUCTS The Procter and Gamble Company (US) 2018-10-24 EP claimed
WO-2017106279-A1 SYNTHESIS OF CYCLOHEXANE ESTER DERIVATIVES USEFUL AS SENSATES IN CONSUMER PRODUCTS THE PROCTER & GAMBLE COMPANY (US) 2017-06-22 WO claimed
US-20170119639-A1 COMPOSITIONS FOR DEPOSITION ON BIOLOGICAL SURFACES PROCTER & GAMBLE (US) 2017-05-04 US claimed
EP-3134081-A2 CYCLOHEXANECARBOXAMIDE WITH COOLING PROPERTIES The Procter & Gamble Company (US) 2017-03-01 EP claimed
US-RE44339-E1 N-substituted P-menthane carboxamides GIVAUDAN S.A. (CH) 2013-07-02 US claimed
EP-2533760-A1 LIQUID COMPOSITION COMPRISING A NON-MENTHOL COOLING AGENT AND A THICKENER FOR TREATING A RESPIRATORY SYMPTOM The Procter & Gamble Company (US) 2012-12-19 EP claimed
WO-2011100267-A1 LIQUID COMPOSITION COMPRISING A NON-MENTHOL COOLING AGENT AND A THICKENER FOR TREATING A RESPIRATORY SYMPTOM THE PROCTER & GAMBLE COMPANY (US) 2011-08-18 WO claimed
US-20110195042-A1 Compositions, Methods and Kits Useful for Treating a Respiratory Symptom THE PROCTER & GAMBLE COMPANY 2011-08-11 US claimed
WO-2011012421-A1 A DENTIFRICE COMPOSITION COMPRISING POLYETHYLENEGLYCOL AND A COOLING AGENT UNILEVER NV (NL) 2011-02-03 WO claimed
EP-2244745-A2 ABSORBENT ARTICLE COMPRISING LOTION COMPOSITION COMPRISING A COOLING AGENT The Procter & Gamble Company (US) 2010-11-03 EP claimed
US-20090240223-A1 ABSORBENT ARTICLE COMPRISING LOTION COMPOSITION COMPRISING A COOLING AGENT PROCTER & GAMBLE COMPANY, THE 2009-09-24 US claimed
WO-2009105740-A2 ABSORBENT ARTICLE COMPRISING LOTION COMPOSITION COMPRISING A COOLING AGENT THE PROCTER & GAMBLE COMPANY (US) 2009-08-27 WO claimed
US-7414152-B2 e. g. N-(4-cyanomethylphenyl) p-menthanecarboxamide; cooling agent in cosmetics and food industries; with additional cooling compound such as menthol, menthone, isopulegol GIVAUDAN, SA (CH) 2008-08-19 US claimed
US-20060276667-A1 N-substituted p-menthane carboxamides GIVAUDAN-SA 2006-12-07 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170119639-A1 COMPOSITIONS FOR DEPOSITION ON BIOLOGICAL SURFACES CUTA, TAS2R40, TAS2R20 TRPM8 54/4885EPHX1 3030/4885SERPINE1 722/4885
US-20110195042-A1 Compositions, Methods and Kits Useful for Treating a Respiratory Symptom MUC1, TAS2R42, TAS2R7 TRPM8 34/4885EPHX1 2455/4885SERPINE1 2626/4885
US-20060276667-A1 N-substituted p-menthane carboxamides ME2, ME3, PYM1 TRPM8 45/4885EPHX1 268/4885SERPINE1 4698/4885
US-20190276389-A1 SYNTHESIS OF ARYL CYCLOHEXANE ESTER DERIVATIVES USEFUL AS SENSATES IN CONSUMER PRODUCTS CUTA, TAS2R8, TRPA1 TRPM8 39/4885EPHX1 1625/4885SERPINE1 3016/4885
US-10871363-B2 Oral care composition with improved deposition efficacy of a cooling sensate agent in the oral cavity ORAI1, TRPM4, TRPM7 TRPM8 11/4885EPHX1 2061/4885SERPINE1 4401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.